| 摘要 |
1335913 Sulphonyl-ureas FARBWERKE HOECHST AG 7 June 1971 [6 June 1970 26 April 1971] 19306/71 Heading C2C Novel compounds (I) (including salts thereof) where X is H, Cl, Br, MeO or Me, Y is or R is C 3 to C 6 alkyl, C 5 to C 8 cycloalkyl optionally substituted by 1 or 2 alkyls of up to 3 carbon atoms in total or by Cl, C 5 to C 8 cycloalkenyl optionally substituted by 1 or 2 alkyls of up to 3 carbon atoms in total, C 7 or C 8 bicyclo-alkyl or -alkenyl, nortricyclyl, spiro[2,4]heptyl, alkylene-imino of 3 to 7 carbons in the ring which may be unsaturated and/or substituted by 1 or 2 methyls or by a C 1 to C 4 alkyl or by a MeO, pentamethylene-imino substituted by C 1 to C 3 endoalkylene, hexamethylene-imino substituted by endoethylene in #,#-position, or tetrahydroisoindoline, 4,7 - endoalkylene - hexahydro- or -tetrahydro-isoindoline the endoalkylene group containing 1 or 2 carbons and the double bond of the tetrahydro-compound being in 5,6-position, are made by standard methods. The following compounds are also prepared: N - [4 - (# - quinolino - 8 - carboxamidoethyl)- benzenesulphonyl] - N<SP>1</SP> - cyclohexyl - thioureaisourea methyl ether and -isothiourea methyl ether. Pharmaceutical preparations suitable for lowering the blood sugar level in the treatment of diabetes mellitus contain (I) as active ingredient; administration is orally. |
